Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	29.62	59.89	46.21
Graham Fair Price	-8.24	36.93	40.25
PEG	26.64	-2.20	-3.00
Price/Book	21.74	3.25	2.67
Price/Cash Flow	243.63	216.39	62.97
Prices/Earnings	39.01	31.87	22.93
Price/Sales	18.26	19.19	16.23
Price/FCF	243.63	216.39	62.97
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-20.56	0.59	0.74
Operating Margin	-18.11	0.24	0.30
ROA	-17.17	< 0.005	< 0.005
ROE	0.03	0.03	-12.42
ROIC	0.02	0.02	-16.43
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.03	0.03	4.56
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.03	-0.19	-439.83
EPS QOQ	-0.08	-0.14	-89.48
FCF QOQ	0.05	-0.66	1157.98
Revenue QOQ	< 0.005	< 0.005	-23.42
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	24.36	100.00
Days Sales Outstanding (DSO)	65.56	65.87	0.47
Inventory Turnover	0.00	3.69	100.00
Debt/Capitalization	0.43	0.45	4.70
Quick Ratio	0.14	0.14	-4.42
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	49.71	48.74	-1.95
Cash	2.00	2.05	2.49
Capex	-0.59	-0.71	-20.60
Free Cash Flow	2.11	0.73	-65.26
Revenue	8.19	8.26	0.94
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.04	1.06	1.81
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	10.23	11.94	16.65
Naive Interpretation	Member

06 - Financial Health · Bad

Rating